Cargando…

Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis

Detalles Bibliográficos
Autores principales:	Khanna, Surabhi Agarwal, Nance, John W., Suliman, Sally A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470721/ https://www.ncbi.nlm.nih.gov/pubmed/36006541 http://dx.doi.org/10.1007/s11926-022-01085-3

Ejemplares similares

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
por: Khanna, Dinesh, et al.
Publicado: (2020)

Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Correction to: Management of Lung Cancer in the Patient with Interstitial Lung Disease
Publicado: (2023)

Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography
por: Khanna, Dinesh, et al.
Publicado: (2022)

Correction: Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
Publicado: (2021)

Correction: Correlating SFTPC gene variants to interstitial lung disease in Egyptian children
por: Abdel Megeid, Azza K., et al.
Publicado: (2022)

Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
por: Fischer, Aryeh, et al.
Publicado: (2019)

Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies
por: Ahmed, Sakir, et al.
Publicado: (2018)

Interstitial lung disease pathology in systemic sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)

Correction to: Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares
por: Chau, Alice S., et al.
Publicado: (2022)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019)

Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017)

Ongoing clinical trials and treatment options for patients with systemic sclerosis–associated interstitial lung disease
por: Khanna, Dinesh, et al.
Publicado: (2019)

Correction: Learnings from clinical trials in patients with connective tissue disease‑associated interstitial lung disease
por: Higuero Sevilla, Jean Paul, et al.
Publicado: (2023)

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
por: Rahaghi, Franck F., et al.
Publicado: (2023)

Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
por: Lota, Harpreet K., et al.
Publicado: (2012)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Correction to: Prediction of progressive pulmonary fibrosis in patients with anti-synthetase syndrome-associated interstitial lung disease
por: Fu, Hongyan, et al.
Publicado: (2023)

Author Correction: Inspiratory Lung Expansion in Patients with Interstitial Lung Disease: CT Histogram Analyses
por: Park, Junghoan, et al.
Publicado: (2019)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis
por: Fox, David A., et al.
Publicado: (2021)

Correction: Early Stage Lung Cancer Detection in Systemic Sclerosis Does Not Portend Survival Benefit: A Cross Sectional Study
Publicado: (2015)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Dyspnoea and cough in patients with systemic sclerosis–associated interstitial lung disease in the SENSCIS trial
por: Volkmann, Elizabeth R, et al.
Publicado: (2022)

Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States
por: Fan, Yanni, et al.
Publicado: (2020)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
por: Tochimoto, Akiko, et al.
Publicado: (2016)

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
por: Vrancken, Anniek, et al.
Publicado: (2015)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Author Correction: The 1-minute sit-to-stand test to detect desaturation during 6-minute walk test in interstitial lung disease
por: Oishi, Keiji, et al.
Publicado: (2022)

Correction to: A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and Bronchiectasis
por: Khan, Tanjila, et al.
Publicado: (2021)

Correction to: Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world
por: Kaku, Sawako, et al.
Publicado: (2022)

Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON
por: Allanore, Yannick, et al.
Publicado: (2022)

An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease
por: Jia, Guiquan, et al.
Publicado: (2023)

Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials
por: Khanna, Dinesh, et al.
Publicado: (2015)

Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management
por: Chowaniec, Małgorzata, et al.
Publicado: (2018)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vo1n6rhj91f0ogikkcpgparpe6